We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWAC
126
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$9.82M 0.05%
1,000,000
FMIV
127
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
$9.76M 0.05%
1,000,000
AAC
128
DELISTED
Ares Acquisition Corporation
AAC
$9.74M 0.05%
1,000,000
LLAP
129
DELISTED
Terran Orbital Corporation
LLAP
$9.73M 0.05%
1,000,000
CRZN
130
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$9.72M 0.05%
1,000,000
CVII
131
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$9.72M 0.05%
1,000,000
GROV icon
132
Grove Collaborative
GROV
$41.9M
$9.71M 0.05%
200,000
QURE icon
133
uniQure
QURE
$3.36B
$9.6M 0.04%
300,000
SVRA icon
134
Savara
SVRA
$1.15B
$8.99M 0.04%
6,512,086
+1,060,000
+19% +$1.43M
VCYT icon
135
Veracyte
VCYT
$3.4B
$8.6M 0.04%
+185,222
New +$8.08M
QSI icon
136
Quantum-Si Incorporated
QSI
$183M
$8.34M 0.04%
1,000,000
-750,000
-43% -$7.39M
ARYD
137
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$8.05M 0.04%
800,000
KCGI.U
138
DELISTED
Kensington Capital Acquisition Corp. V Units, each consisting of one Class A ordinary share and three-fourths of one redeemable warrant
KCGI.U
$7.91M 0.04%
+775,200
New +$7.84M
JWSM
139
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$7.81M 0.04%
800,000
LVRA
140
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$7.81M 0.04%
800,000
PSPC
141
DELISTED
Post Holdings Partnering Corporation
PSPC
$7.71M 0.04%
+800,000
New +$7.75M
SURF
142
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7.57M 0.04%
1,000,000
AUR icon
143
Aurora
AUR
$12.5B
$7.45M 0.03%
750,000
EQRX
144
DELISTED
EQRx, Inc. Common Stock
EQRX
$7.44M 0.03%
+750,000
New +$7.51M
MVLA
145
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$7.41M 0.03%
750,000
DRIO icon
146
DarioHealth
DRIO
$73.4M
$7.37M 0.03%
27,000
WPCA
147
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
$7.37M 0.03%
750,000
ARYE
148
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$7.36M 0.03%
+745,000
New +$7.4M
YTPG
149
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$7.36M 0.03%
750,000
CPAR
150
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$7.35M 0.03%
+753,900
New +$7.32M

Similar funds

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.